Four BIG reports have been released and are very much worth reviewing -- 1. Global AMR R&D Hub and the World Health Organization AMR Team have written a report entitled “Incentivising the development of new antibacterial treatments“. 2. Biomedical Advanced Research and Development Authority (BARDA) have released their 2022-2026 Strategic Plan. 3. The UK’s Fleming Fund recently released a major AMR report on its progress to date. 4. Centers for Disease Control and Prevention reports having awarded more than $36 million for innovative research on AMR topics to diverse partners during Fiscal Year 2021 both within the United States and globally. Well done to our colleagues around the world who did this excellent work! #AMR #AMRSOS #StopSuperbugs #Antibiotics #AntimicrobialStewardship #AntibioticResistance #Medicine #Science #Health #Progress #FireExtinguishersOfMedicine https://lnkd.in/gWAnsvxu
AMR.Solutions
制药业
Newsletter curated by Dr. John H. Rex that is focused on the latest about antimicrobials and antibiotic resistance.
关于我们
The Antimicrobial Resistance Solutions newsletter delivers the latest about antibiotics and antimicrobials to your inbox. Personally curated by Dr. John H. Rex and only sent when there is something to say, the aim of this newsletter is to encourage the global efforts of new agent development.
- 网站
-
https://amr.solutions/
AMR.Solutions的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Massachusetts
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Antibiotics、Antimicrobials、Medicine、Pharmaceuticals、Antibiotic Resistance、Antimicrobial Resistance、Science、Health、Antibiotic Stewardship、Antimicrobial R&D和R&D Insight
地点
-
主要
获取路线
US，Massachusetts
AMR.Solutions员工
动态
-
For #WAAW24, I ask you to take a moment to celebrate the World Health Organization Task Force of Antimicrobial Resistance Survivors. Two of its members, Rob Purdie and Ella Balasa, joined me for a Fireside Chat to share their stories and details of their work so far. I really want to encourage you to take time to watch the video. It’s one thing to read a summary, it is another to hear their voices! YouTube ?? https://lnkd.in/eb4tfugr Newsletter?? https://lnkd.in/eD_tMB5u #StopSuperbugs #AMRSOS #WAAW #Medicine #Antimicrobial #AntibioticResistance #Science #Health #Advocacy #AntimicrobialResistance #Antibiotics are the #FireExtinguishersOfMedicine! ??????
Episode 17 w/ Ella Balasa and Rob Purdie of WHO Task Force of AMR Survivors - AMR Fireside Chat
https://www.youtube.com/
-
The Fleming Initiative billboard in New York City's Times Square is very cool to see during the United Nations General Assembly! The High Level Meeting on AMR is happening today -- go watch it live here! https://t.co/34qEkkPSs3 #Antibiotic #AMR #Antimicrobial #AntibioticResistance #AntimicrobialResistance #Superbugs #AMRSOS #StopSuperbugs #Science #Health #Medicine #Medical #ActNow ?? #Antibiotics are the #FireExtinguishersOfMedicine! ??????
-
Last week?I went to New York City to see one of the opening performances of?Lifeline,?The Musical,?the world’s first musical telling the story of penicillin, Sir Alexander Fleming, and the rise of antibiotic resistance!?This was my first time seeing the production in its entirety and it did not disappoint. The timing of this 5-week run of the show aligns with the upcoming?26 Sep 2024 United Nations General Assembly HLM (High-Level Meeting) on AMR, hopefully generating enhanced awareness of AMR. I had a chance to talk to show creator Robin Hiley backstage before the show and it was a fabulous experience. Watch this video for the interview and my review of the show! Read more of my review at https://lnkd.in/gtpEWTd6 ?????? #Science #Antibiotics #Broadway #AntimicrobialResistance #AntibioticResistance #StopSuperbugs #AMRSOS #Medicine #Health #FireExtinguishersOfMedicine ?? https://lnkd.in/gHMABzQk
Lifeline: The Musical - Interview w/Creator Robin Hiley and Show Review by Dr. John Rex
https://www.youtube.com/
-
Wonderful to see the support of the AMR Action Fund at work! Well done to all! ?? #FireExtinguishersOfMedicine ???? #Science #Medicine #Health #News #AntibioticStewardship
Congratulations to the team at UTILITY Therapeutics, an AMR Action Fund portfolio company, which has been granted FDA approval for Pivya (pivmecillinam) to treat uncomplicated urinary tract infections (uUTIs). Pivya marks the first drug in approximately 20 years approved by the FDA for uUTIs, and it represents the first antibiotic from one of our portfolio companies to earn approval. This is a milestone for the AMR Action Fund, but more importantly, it is a key step forward for patients and clinicians. UTIs are common, affecting some 15 million women in the U.S. per year, and can be debilitating.?Providing a safe and effective first-line treatment option will benefit patients suffering from these harmful infections while enhancing antimicrobial stewardship efforts.